By Tony St. James, Marion Kirkpatrick
RFD-TV
U.S. sugar demand remains firm, but wider use of GLP-1 weight-loss medications and growing health concerns could weaken the market over time. CoBank food and beverage economist Billy Roberts says producers should focus less on current stability and more on how consumption patterns may shift.